Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell linesMichela Levi(University of Bologna), Giuseppe Sarli(University of Bologna)BMC Veterinary ResearchJanuary 18, 202110.1186/s12917-020-02709-5Cited by 25SaveCiteExport RISWatch citationsRelated PapersPDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems|Veterinary Pathology|2023|8